# A Phase I Clinical Study of HMPL-A83 in Patients With Advanced Malignant Neoplasm

> **NCT05429008** · PHASE1 · COMPLETED · sponsor: **Hutchmed** · enrollment: 40 (actual)

## Conditions studied

- Advanced Tumors

## Interventions

- **DRUG:** HMPL-A83 injection

## Key facts

- **NCT ID:** NCT05429008
- **Lead sponsor:** Hutchmed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-15
- **Primary completion:** 2025-04-07
- **Final completion:** 2025-04-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05429008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05429008, "A Phase I Clinical Study of HMPL-A83 in Patients With Advanced Malignant Neoplasm". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05429008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*